Kyowa Kirin is a global specialty pharmaceutical company backed by more than 70 years of breakthrough life science innovation, dedicated to discovering and advancing treatments for diseases in which unmet need is greatest. Based in Japan with worldwide operations, we work across the continuum from drug discovery to commercialization, guided by our commitment to patients and their families.

Our research teams, located in California and around the world, are focused on developing the next generation of antibody, cell, and gene therapies, with particular emphasis on bone and mineral disorders, hemato-oncology, and rare diseases. We accelerate development through collaborations with industry, academia, patients, and healthcare providers, and since 2018 we have introduced four new therapies serving patients with progressive illnesses often in need of new therapeutic alternatives.

Our culture is grounded in our values: Commitment to Life, Integrity, Innovation, and Teamwork/Wa, and brought to life through the Kabegoe Principles, which define the behaviors and actions that guide how we work together to deliver meaningful impact for patients.

We’re proud of the progress we’ve made and mindful of the countless individuals still waiting for their own breakthroughs. A commitment to making people smile unites our efforts. Learn more at www.kkna.kyowakirin.com.

Summary

The Principle I, GRA-CMC is responsible for providing site-based global regulatory CMC leadership and support for the Sanford manufacturing facility. The role serves as the primary interface between the Sanford site and the global GRA-CMC organization, ensuring that site regulatory activities are aligned with global regulatory strategy, applicable requirements, and business priorities.

The role is responsible for regulatory activities associated with the FDA PreCheck pilot program and the Sanford Type V DMF, as well as providing GRA-CMC representation for site technology transfer activities. The position also provides regulatory CMC support to address the evolving regulatory requirements of the Sanford site and development pipeline.

Essential Functions

• Serve as the primary GRA-CMC interface for the Sanford site, providing regulatory CMC leadership, strategic guidance, and oversight to ensure site activities are aligned with global regulatory strategies, applicable requirements, and company standards.

• Direct GRA-CMC activities associated with the FDA PreCheck program, including preparation for FDA interactions, regulatory communications, responses to agency requests, and associated follow-up activities.

• Own the preparation, submission, and lifecycle management of the Sanford Type V DMF, ensuring that content remains accurate, current, and aligned with applicable regulatory requirements and product development and manufacturing activities.

• Represent GRA-CMC within Sanford technology transfer activities, ensuring regulatory requirements, filing considerations, and regulatory commitments are identified early and appropriately incorporated into technical strategies and execution plans.

• Assess regulatory CMC implications of Sanford site changes and manufacturing activities, including facility readiness, process and equipment changes, technical initiatives, and other site-related activities with potential regulatory impact.

• Establish and maintain effective partnerships with Sanford Quality, Manufacturing, MSAT, Supply Chain, and other technical functions, as well as global GRA-CMC and development teams, to ensure timely identification, assessment, and resolution of regulatory CMC matters.

• Proactively identify and evaluate regulatory CMC risks, developing appropriate mitigation strategies to support compliant and timely execution of site and development activities.

• Contribute to regulatory submissions and health authority interactions for products manufactured or planned to be manufactured at Sanford, including assessment of CMC information, responses to regulatory questions, and other activities as required.